4Stoop JN, van der Molen RG, Kuipers EJ, et al. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic' hepatitis B [J]. Virology,2007,361 ( 1 ) : 141 - 148.
5Westland CE, Yang H, Delaney WE 4th, et al. Activity of adeforir dipivoxil against all patterns of lamivudine - resistant hepatitis B viruses in patients[J]. J Viral Hepat,2005,12:67 -73.
4Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
6Shaw JP,Louie MS,Krishnamurthy VV,et al.Pharmacokinetics and metabolism of selected prodrug of PMEA in rats.Drug Metab Dispos,1997,25 (3):362
7Biessen Eal,Valentijn Arpm,Vrueh Rlade,et al.Novel hepatotrophic prodrugs of the antiviral nuleoside 9-(2-phosphonyl methoxyethyl) adenine with improved pharmacokinetics and antiviral activity.Faseb J,2000,14 (12):1784
8Cundy KC,Sue IL,Visor GC,et al.Oral formulations of adefovir dipivoxil in vitro dislution and in vivo bioaviailability in dogs.J Pharm Sci,1997,86 (12):1334
9Cundy KC,Fishback JA,Shaw PC,et al.Oral bioavailability of the antiretroviral agent 9-(2-phosphonyl methoxyethyl) adenine (PMEA)from three formulations of the prodrug bis (pivaloyloxymethyl) -PMEA in fasted male cynomolgus monkeys.Pharm Re,1994,11 (6):839
10Naesens L,Balzarini J,Bischofberger N,et al.Antiretroviral activity and pharmacokinetics in mice of oral bis (pivaloyloxymethyl) -9-(2-phosphonyl methoxy-ethyl) adenine,the bis (pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxy-ethyl) adenine.Antimicrob Agents Chemother,1996,40 (1):22
